HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer.

Purpose: New generation of receptor tyrosine kinase inhibitors (RTKIs) have shown to improve survival in many solid tumors. However, an imaging biomarker is needed for patient selection and prediction of treatment response. This study evaluates the use of quantitative changes of HER3 on 68 Ga-NOTA-H...

Descripción completa

Detalles Bibliográficos

Publicado en:	Molecular Imaging & Biology Vol. 25; no. 2; pp. 353 - 363
Autores principales:	Esfahani, Shadi A., de Aguiar Ferreira, Carolina, Rotile, Nicholas J., Ataeinia, Bahar, Krishna, Shriya, Catalano, Onofrio A., Caravan, Peter, Yen, Yi-Fen, Heidari, Pedram, Mahmood, Umar
Formato:	Journal Article
Publicado:	Springer Nature Apr2023
Acceso en línea:	Ver este registro en EBSCOhost